ASM vs MUX

ASM presents a paradoxical profile with a stable Piotroski F-Score of 4/9 and exceptional balance sheet health, yet it trades at a significant premium to its Graham Number ($2.35) and Intrinsic Value ($5.02). While YoY earnings growth is explosive (82.90%) and margins are robust, the company has failed to beat earnings estimates in the last four consecutive quarters with a severe average surprise of -30.56%. The stark contrast between the 'Strong Buy' analyst consensus and the bearish technical trend/poor earnings track record suggests a high-risk growth play dependent on future production targets rather than current execution.

MUX presents a stark contrast between weak deterministic health and explosive growth expectations. The Piotroski F-Score of 3/9 indicates weak financial health, and the current price of $21.03 trades at a significant premium to both the Graham Number ($11.43) and Intrinsic Value ($4.13). However, the company is experiencing massive revenue growth (92.8% YoY) and a very attractive Forward P/E of 4.57, suggesting a pivot toward significant profitability. The stock is currently a high-risk growth play where market sentiment and analyst targets ($31.70) outweigh current fundamental stability.